Eicosatetraynoic and arachidonic acid-induced changes in cell membrane fluidity consonant with differences in...

Area of Science:

• Biochemistry and Molecular Biology
• Cell Biology
• Cancer Research

Background:

• 5,8,11,14-eicosatetraynoic acid (ETYA) is a competitive analogue of arachidonic acid (AA).
• ETYA inhibits the proliferation of U937 and PC3 cancer cells.
• The mechanism of ETYA's anti-proliferative effect and its cytotoxicity profile compared to AA are not fully established.

Purpose of the Study:

• To investigate the mechanism by which ETYA inhibits cancer cell proliferation.
• To compare the effects of ETYA and AA on cell membrane fluidity.
• To explore the structural basis for the differential effects of ETYA and AA on membrane fluidity and cell proliferation.

Main Methods:

• Measurement of whole cell and isolated microsomal membrane fluidity using fluorescence polarization (TMA-DPH and DPH probes).
• Incubation of PC3 cells with ETYA for 72 hours to assess long-term effects on membrane fluidity.
• Molecular mechanics and molecular dynamics simulations to determine the intramolecular conformational profiles of ETYA and AA.

Main Results:

• ETYA significantly increased membrane fluidity in U937 and PC3 cells at 100 microM, to a greater extent than AA.
• ETYA's structural features, including kink-deformed conformers due to alkyne bonds, result in larger molecular cross-sections compared to AA.
• A dissociation was observed between the extent of membrane fluidity changes and DNA synthesis inhibition, suggesting distinct roles for ETYA and AA.

Conclusions:

• ETYA's greater ability to increase membrane fluidity is linked to its anti-proliferative effects on cancer cells.
• The structural differences between ETYA and AA underlie their distinct impacts on membrane fluidity.
• Increased membrane fluidity induced by ETYA is likely crucial for inhibiting DNA synthesis, while AA's effects are insufficient or qualitatively different.